QUOTE AND NEWS
newratings.com  Jun 23  Comment 
WASHINGTON (dpa-AFX) - ArQule, Inc. (ARQL) Thursday said it plans to present the preliminary data from the ongoing phase 2 portion of a phase 1/2 trial in intrahepatic cholangiocarcinoma with proprietary fibroblast growth factor receptor...
newratings.com  May 4  Comment 
WASHINGTON (dpa-AFX) - ArQule, Inc. (ARQL) said the company expects fiscal 2016 net loss to range between $24 and $27 million, and net loss per share to range between $0.34 and $0.39. The company expects revenues to range between $4 and $5...
newratings.com  Mar 1  Comment 
TOKYO (dpa-AFX) - ArQule Inc. (ARQL) and Daiichi Sankyo announced that the independent data monitoring committee or DMC of the METIV-HCC study conducted the planned interim assessment and it was determined the trial will continue to its final...
Benzinga  Dec 21  Comment 
RBC Capital upgraded ArQule, Inc. (NASDAQ: ARQL) from Sector Perform to Outperform. Arqule shares closed at $2.05 on Friday. Analysts at Jefferies upgraded Tiffany & Co. (NYSE: TIF) from Hold to Buy. The price target for Tiffany has been...
newratings.com  Dec 15  Comment 
WASHINGTON (dpa-AFX) - ArQule, Inc. (ARQL) Tuesday announced receipt of orphan drug designation from the Food and Drug Administration for ARQ 087 in cholangiocarcinoma. ARQ 087 is a multi-kinase inhibitor designed to preferentially inhibit...





 




References

Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki